Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10011432181
The Brazilian pharmaceutical industry has always been targeted by the society, due to the ethical drugs' high weight in the families' consumption budgets (especially within the poorer ones) and price raises traditionally above inflation (when the government does not run a price control). The...
Persistent link: https://www.econbiz.de/10011761546
Persistent link: https://www.econbiz.de/10001629086
Persistent link: https://www.econbiz.de/10002120765
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) came into force in 1995 in the ambit of the World Trade Organization (WTO). TRIPS obliges WTO country members to adopt higher standards of patent protection and, as a consequence, increases the costs of access to...
Persistent link: https://www.econbiz.de/10009231383
Persistent link: https://www.econbiz.de/10003025589
The pharmaceutical industry invests its sales force in contacts with doctors, making visits and publicizing its drugs, in orderfor them to prescribe these products to their patients. This work discusses the structure of the pharmaceutical market and howmarketing strategies are used by...
Persistent link: https://www.econbiz.de/10009446936
Comparative analysis of the industrial concentration and turnover of the pharmaceutical industry in Brazil for the segments of mark and generic drugs - This paper analyzes the evolution of brand-name and generic drugs structure in Brazil since 1997. After the introduction of generic drugs it was...
Persistent link: https://www.econbiz.de/10008467341
Persistent link: https://www.econbiz.de/10011473163